期刊文献+

CVE方案结合局部治疗对31例眼内期视网膜母细胞瘤患儿的疗效观察 被引量:3

Efficacy Observation of CVE Scheme Combined with Local Treatments for 31 Children with Intraocular Retinoblastoma
原文传递
导出
摘要 目的:探讨CVE方案结合局部治疗对儿童眼内期视网膜母细胞瘤的疗效。方法:选取2008年6月-2011年6月我科收治的眼内期视网膜母细胞瘤患儿,对其临床数据进行分析。采用CVE方案结合局部治疗的方法治疗。结果:共31例(40只患眼),其中单侧患儿22例,双侧患儿9例,平均年龄22.8个月,平均随访27.8个月。采用Reese-Ellsworth分级法,17只眼为Ⅰ~Ⅲ级,治疗后16只眼(94.1%)持续缓解,1只眼(5.9%)仍发生进展;23只眼为Ⅳ~Ⅴ级,治疗后9只眼(39.1%)持续缓解,14只眼(60.9%)出现肿瘤复发或新发病灶。所有病例都能耐受化疗,仅4例(12.9%)发生轻度肝功能损害。结论:CVE方案与局部治疗相结合,可以对眼内期视网膜母细胞瘤进行有效的治疗,降低外照射放疗及眼球摘除手术的应用率,提高患儿生存质量。 OBJECTIVE:To explore therapeutic efficacy of CVE combined with local treatments for children with intraocular retinoblastoma. METHODS:Children with intraocular retinoblastoma admitted in our department during Jun. 2008-Jun. 2011 were enrolled in the study,and clinical data were analyzed. RESULTS:There were 40 eyes of 31 children,22 children were unilateral disease and 9 children were bilateral disease. Mean age of the children was 22.8 months,and mean follow-up period was 27.8 months. According to Reese-Ellsworth classification,17 eyes wereⅠ-Ⅲ,16 eyes(94.1%)were in complete remission,1 eye(5.9%)pro- gressed;23 eyes were Ⅳ-Ⅴ,9 eyes(39.1%)were in complete remission,and other 14 eyes(60.9%)suffered from tumor reoccurrence or new disease. All children could tolerate chemotherapy,only 4 children(12.9%)occurred mild hepatotoxicity. CONCLUSIONS:The combination of CVE and local treatment is effective for intraocular retinoblastoma,which can eliminate the application rate of external beam radiotherapy or enucleation and improve the quality of life in retinoblastoma children.
出处 《中国药房》 CAS CSCD 2013年第26期2444-2446,共3页 China Pharmacy
关键词 CVE方案 眼内期 视网膜母细胞瘤 局部治疗 CVE scheme Intraocular Retinoblastoma Local treatment
  • 相关文献

参考文献13

二级参考文献85

共引文献19

同被引文献35

  • 1程翼飞,张乐萍,刘桂兰,黎晓新.局部治疗加化疗治疗眼内视网膜母细胞瘤[J].中国斜视与小儿眼科杂志,2004,12(2):49-51. 被引量:8
  • 2杨新吉,李月月,王毅,李天臣,黑砚,魏红,陈学国,肖利华.视网膜母细胞瘤的化学减容治疗[J].眼科新进展,2007,27(2):135-137. 被引量:8
  • 3甄子俊,孙晓非,夏奕,凌家瑜,郑磊,罗文标,林慧.成人常用镇痛药治疗儿童癌痛的可行性及疗效[J].癌症,2007,26(8):866-869. 被引量:9
  • 4MacCarthy A, Birch JM, Draper GJ, et al. Retinoblasto- ma: Treatment and survival in Great Britain 1963 to 2002 [J]. Br J Ophthalmol, 2009,93 ( 1 ) : 38.
  • 5Canturk S, Qaddoumi I, Khetan V, et al. Survival of reti- noblastoma in less-developed countries Impact of socio- economic and health-related indicators[J].Br J Ophthal- mol,2010,94(11) : 1 423.
  • 6Shields CL, Mashayekhi A, Cater J, et al. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors[J]. American Journal of Oph- thalmology, 2004, 138 (3) : 329.
  • 7Mercadante S, Giarratano A. Pharmacological manage-ment of cancer pain in children[J]. Critical Reviews in On- tologyHematology, 2014,91 ( 1 ) : 93.
  • 8Borges HL, Hunton IC, Wang JY. Reduction of apoptosis in Rb-deficient embryos via Abl knockout[J]. Oncogene, 2007,26(26) :3 868.
  • 9Chau BN, Borges HL, Chen TT, et al. Signal-dependent protection from apoptosis in mice expressing caspase-re- sistant Rb[J]. Nat Cell Biol, 2002,4(10) : 757.
  • 10Dirlam A, Spike BT, MacLeod KF. Deregulated E2f-2 un- derlies cell cycle and matration defects in retino-blastoma null erythroblasts[J]. Mol Cell Biol, 2007,27(24) : 8 713.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部